Pages that link to "Q37256639"

The following pages link to Cognitive dysfunction is associated with poor socioeconomic status in patients with cirrhosis: an international multicenter study (Q37256639):

Displaying 20 items.

• From prolonging life to prolonging working life: Tackling unemployment among liver-transplant recipients (Q26748600) (← links)
• GABAA receptor modulating steroid antagonists (GAMSA) are functional in vivo (Q26777461) (← links)
• Validation of EncephalApp, Smartphone-Based Stroop Test, for the Diagnosis of Covert Hepatic Encephalopathy (Q33440948) (← links)
• Covert hepatic encephalopathy is independently associated with poor survival and increased risk of hospitalization (Q35064105) (← links)
• Cognitive reserve is a determinant of health-related quality of life in patients with cirrhosis, independent of covert hepatic encephalopathy and model for end-stage liver disease score (Q35498468) (← links)
• Impact of Hepatitis C Virus Infection on Cognitive Function in Patients With Covert Hepatic Encephalopathy (Q35964960) (← links)
• Social-Economic Status and Cognitive Performance among Chinese Aged 50 Years and Older (Q36197412) (← links)
• Recent developments in the diagnosis and treatment of covert/minimal hepatic encephalopathy. (Q38693964) (← links)
• The 3-month readmission rate remains unacceptably high in a large North American cohort of patients with cirrhosis (Q40185640) (← links)
• Risk and adverse outcomes of fractures in patients with liver cirrhosis: two nationwide retrospective cohort studies (Q42376792) (← links)
• Covert Hepatic Encephalopathy: Can My Patient Drive? (Q45049715) (← links)
• Years of life lost (Yll) attributable to alcohol consumption in Mexico City (Q48876071) (← links)
• The burden of minimal hepatic encephalopathy: from diagnosis to therapeutic strategies. (Q50532497) (← links)
• Diagnosis of Minimal Hepatic Encephalopathy: A Systematic Review of Point-of-Care Diagnostic Tests. (Q52658321) (← links)
• Systematic Review of the Economic Burden of Overt Hepatic Encephalopathy and Pharmacoeconomic Impact of Rifaximin. (Q55381916) (← links)
• Proton pump inhibitors are associated to minimal and overt hepatic encephalopathy and increase mortality in cirrhotics (Q56980578) (← links)
• Quality of life in patients with minimal hepatic encephalopathy (Q60929935) (← links)
• Impact of Hepatic Encephalopathy in Cirrhosis on Quality-of-Life Issues (Q64263567) (← links)
• Sarcopenia and cognitive impairment in liver cirrhosis: A viewpoint on the clinical impact of minimal hepatic encephalopathy (Q90318350) (← links)
• Association between socioeconomic status and cognitive functioning among older adults in Ghana (Q102213257) (← links)